Anne Nunes - 19 Jun 2023 Form 3 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
SVP, Chief Operations Officer
Signature
/s/ Anne Nunes
Issuer symbol
ANIK
Transactions as of
19 Jun 2023
Net transactions value
$0
Form type
3
Filing time
26 Jun 2023, 16:54:00 UTC
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ANIK Common Stock 3,293 19 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ANIK Restricted Stock Unit 19 Jun 2023 Common Stock 4,982 $0.000000 Direct F1
holding ANIK Stock Option (Right to Buy) 19 Jun 2023 Common Stock 8,640 $43.27 Direct F2
holding ANIK Stock Option (Right to Buy) 19 Jun 2023 Common Stock 9,225 $47.60 Direct F2, F3
holding ANIK Restricted Stock Unit 19 Jun 2023 Common Stock 5,122 $0.000000 Direct F4
holding ANIK Stock Option (Right to Buy) 19 Jun 2023 Common Stock 8,763 $28.14 Direct F3, F5
holding ANIK Restricted Stock Unit 19 Jun 2023 Common Stock 9,886 $0.000000 Direct F6
holding ANIK Stock Option (Right to Buy) 19 Jun 2023 Common Stock 10,629 $29.60 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents the contingent right to receive one share of the Company's common stock. 7,473 RSUs were granted on October 1, 2021 and the RSUs vest in three equal annual installments beginning October 1, 2022.
F2 The stock options vest in three equal annual installments beginning on October 1, 2022.
F3 Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
F4 Each RSU represents the contingent right to receive one share of the Company's common stock. 7,683 RSUs were granted on March 11, 2022 and the RSUs vest in three equal annual installments beginning March 11, 2023.
F5 The stock options vest in three equal annual installments beginning on March 11, 2023.
F6 Each RSU represents the contingent right to receive one share of the Company's common stock. 9,886 RSUs were granted on March 9, 2023 and the RSUs vest in three equal annual installments beginning March 9, 2024.
F7 The stock options vest in three equal annual installments beginning on March 9, 2024.